TrialInternational journal of hematology2017

Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan.

Kiyohiko Hatake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.